About Petz Aladar Megyei Oktato Korhaz
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Hoffmann-La Roche
17
Janssen Research & Development, LLC
8
Merck Sharp & Dohme LLC
6
Celgene
5
Amgen
4
Henogen
4
Ipsen
4
Eli Lilly and Company
3
Petz Aladar County Teaching Hospital
3
Pfizer
3
Pierre Fabre Medicament
3
Clinical Trials at Petz Aladar Megyei Oktato Korhaz
During the past decade, Petz Aladar Megyei Oktato Korhaz conducted 62 clinical trials. In the 10-year time frame, 62 clinical trials started and 40 clinical trials were completed, i.e. on
average, 64.5% percent of trials that started reached the finish line to date. In the past 5 years, 27 clinical trials started and 20 clinical trials were completed. i.e. 74.1%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
A Study of Combination Thalidomide Plus Dexamethasone Therapy vs. Dexamethasone Therapy Alone in Previously Untreated Subjects With Multiple Myeloma
2003-02-01
2013-08-01
Completed
470
Study of MEDI-524 (Motavizumab) for the Prophylaxis of Serious Respiratory Syncytial Virus (RSV) Disease in High-Risk Children
2004-11-01
2006-05-01
Completed
6,635
A Study of Anagrelide and Hydroxyurea in High-Risk Essential Thrombocythemia Patients
2006-01-13
2015-12-15
Completed
150
A Study to Compare the Immune Response and Safety Elicited by Henogen's Adjuvanted Hepatitis B Vaccine Compared to GSK Biologicals Adjuvanted Hepatitis B Vaccine in Pre-Dialysis and Dialysis Patients Who Have Not Been Exposed to Hepatitis B.
2006-02-01
2007-03-01
Completed
300
Compare the Immune Response & Safety Elicited by Henogen's Adjuvanted Hepatitis B Vaccine vs Aventis Pasteur MSD's Hepatitis B Vaccine in Pre-Dialysis & Dialysis Patients Who Did Not Respond to Previous Hepatitis B Vaccination
2006-03-01
2007-10-01
Completed
257
A Study to Compare the Immune Response and Safety Elicited by Henogen's Adjuvanted Hepatitis B Vaccine Compared to Aventis Pasteur MSD's Hepatitis B Vaccine in Pre-Dialysis and Dialysis Patients Who Responded to Previous Hepatitis B Vaccination But Lost Antibody.
2006-03-01
2007-10-01
Completed
185
Study of COLAL-PRED® in the Treatment of Moderate Acute Ulcerative Colitis
2006-03-01
2008-04-01
Completed
796
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "Petz Aladar Megyei Oktato Korhaz" #1 sponsor was "Hoffmann-La Roche" with 17 trials, followed by "Janssen Research & Development, LLC" with 8 trials
sponsored, "Merck Sharp & Dohme LLC" with 6 trials sponsored, "Celgene" with 5 trials sponsored and "Amgen"
with 5 trials sponsored. Other sponsors include 74 different institutions and
companies that sponsored additional 63 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Petz Aladar Megyei Oktato Korhaz"
#1 collaborator was "GlaxoSmithKline" with 3 trials as a collaborator, "Bristol-Myers Squibb" with 2 trials as a collaborator, "Merck KGaA, Darmstadt, Germany" with 2 trials as a collaborator, "APCER Life Sciences" with 1 trials as a collaborator and "AbbVie" with 1 trials as a collaborator. Other collaborators include 14 different institutions and companies that were
collaborators in the rest 24 trials.
Clinical Trials Conditions at Petz Aladar Megyei Oktato Korhaz
According to Clinical.Site data, the most researched conditions in "Petz Aladar Megyei Oktato Korhaz" are
"Ulcerative Colitis" (7 trials), "Carcinoma, Non-Small-Cell Lung" (6 trials), "Myelofibrosis" (5 trials), "Primary Myelofibrosis" (5 trials) and "Hepatitis B" (4 trials). Many other conditions were trialed in "Petz Aladar Megyei Oktato Korhaz" in a lesser frequency.
Clinical Trials Intervention Types at Petz Aladar Megyei Oktato Korhaz
Most popular intervention types in "Petz Aladar Megyei Oktato Korhaz" are "Drug" (103 trials), "Biological" (19 trials), "Other" (13 trials), "Procedure" (4 trials) and "Device" (2 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (33 trials), "placebo" (6 trials), "Bevacizumab" (5 trials), "Etrolizumab" (5 trials) and "Gemcitabine" (5 trials). Other intervention names were less common.
Clinical Trials Genders at Petz Aladar Megyei Oktato Korhaz
The vast majority of trials in "Petz Aladar Megyei Oktato Korhaz" are
109 trials for "All" genders, 5 trials for "Female" genders and 5 trials for "Male" genders.
Clinical Trials Status at Petz Aladar Megyei Oktato Korhaz
Currently, there are NaN active trials in "Petz Aladar Megyei Oktato Korhaz".
undefined are not yet recruiting,
19 are recruiting,
19 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 71 completed trials in Petz Aladar Megyei Oktato Korhaz,
undefined suspended trials,
and 8 terminated clinical trials to date.
Out of the total trials that were conducted in Petz Aladar Megyei Oktato Korhaz, 1 "Phase 1"
clinical trials were conducted, 26 "Phase 2" clinical
trials and 83 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 3 trials, and there were
also 4 trials that are defined as “Not Applicable".
Departments of Petz Aladar Megyei Oktato Korhaz
Petz Aladar Megyei Oktato Korhaz has several departments that took part in Clinical trials: "Petz Aladar Megyei Oktato Korhaz; Oncoradiologia" - 3 trials, "Petz Aladar Megyei Korhaz; Hematologia" - 6 trials, "Petz Aladar Megyei Oktató Kórház, Onkoradiológia" - 2 trials
Departments List